Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR‐TKIs in advanced non‐small cell lung cancer: A systematic review and network meta‐analysis

BACKGROUND: The combination of antiangiogenic agents with epidermal growth factor receptor inhibitors (EGFR‐TKIs) and chemotherapy with EGFR‐TKIs are the most common combination treatment options in epidermal growth factor receptor (EGFR) positive non‐small cell lung cancer (NSCLC). This network met...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Jiali, Liu, Xinyin, Li, Jun, Qu, Tianyu, Cui, Yanan, Jin, Shidai, Zhang, Erbao, Guo, Renhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968601/
https://www.ncbi.nlm.nih.gov/pubmed/36594109
http://dx.doi.org/10.1111/1759-7714.14783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968601/
https://www.ncbi.nlm.nih.gov/pubmed/36594109
http://dx.doi.org/10.1111/1759-7714.14783

Ejemplares similares